Hints and tips:
...That entity was set up to sell NSO products in the US, according to several people familiar with the matter....
...Lake Nona Fund / LN Sports & Health Tech Fund I, LP . . . Exponent Founders Capital I, LP . . . SH Fund, LP . . . Curated [chef recommends] . . . Race Capital II, LP . . ....
...Catherine Powell, who heads Airbnb’s experiences product, will become head of Hosting, a newly created division that will incorporate her existing areas and home-sharing. More here....
...It is now looking for net product sales in the range of $24bn-$25bn, compared the previous range of $22.5bn to $24.5bn....
...The acquisition of Capsugel, which manufactures and sells drug capsules, will allow cross-selling of existing products and to combine manufacturing services....
...It became the first product to receive abuse-deterrent labelling from the FDA in 2013....
...“We want to show the farmers how they can collect the product and at some point we will show this to private investors,” says Tesama....
...More than $260bn of deals were struck in the pharmaceuticals, biotech and medical products sectors the first half of this year – the highest on record and more than twice the level of the same period last...
...(NYT$) Food for thought This is not the year for personalisation Most companies still stick with mass production and common product configurations, while products that are too bespoke turn people off....
...Good morning New York, FT ALPHAVILLE Paul notes the rush of biotech IPOs, product not required. Barclay’s has a weird pre-announcement....
...(Financial Times) Amgen reached a deal on Sunday to buy fellow biotech company Onyx Pharmaceuticals for about $10.4bn, in an all-cash takeover that values Onyx at $125 a share....
...The case involved patents by Myriad Genetics, a Utah biotech company, on two genes whose mutations have been linked to breast and ovarian cancer....
...PPD is a contract research organisation for pharmaceutical, biotech and medical device companies....
...Shire, the Dublin-based maker of treatments for attention deficit disorder, said on Wednesday it had agreed to buy closely held Advanced BioHealing for $750m in cash, a day before the biotech company was...
...In its decision the US Court of Appeals for the Federal Circuit in Washington found the original patent held by Centocor Ortho Biotech, a unit of J&J, and New York University, was invalid....
...NCPharma has set itself the ambition of securing from the world’s largest drugs companies parts of their product pipelines....
...from upstarts who have capitalized on the big biotech’s manufacturing missteps....
...The deal will help Sanofi strengthen its product range as it faces a series of patent expiries on existing so-called blockbusters....
...Sanofi-Aventis has ended a nine-month pursuit of US biotech company Genzyme with a $20.1bn deal worth $74 a share, Bloomberg says....
...What Blackstone can offer instead is experience in managing consumer products companies....
...Biotech, a unit of Cougar Biotechnology....
...Facet Biotech jumped 66.6 per cent to $27.01 after Abbott Laboratories, which makes the arthritis drug Humira, agreed to buy the biotech company for $27 per share, valuing the company at about $450m....
...The terms of the agreement between J&J’s subsidiary Centocor Ortho Biotech and Schering-Plough allow arbitration within 30 days of a change of ownership....
...Venture capitalists have begun to shun high-risk bets such as biotech. Meanwhile, the public funding market has all but dried up....
International Edition